Comparing Enfusion (NYSE:ENFN) & NetObjects (OTCMKTS:NETO)

Enfusion (NYSE:ENFN) and NetObjects (OTCMKTS:NETO) are both computer and technology companies, but which is the better investment? We will compare the two businesses based on the strength of their valuation, risk, analyst recommendations, profitability, institutional ownership, dividends and earnings.

Valuation & Earnings

This table compares Enfusion and NetObjects”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Enfusion	$201.61 million	6.94	$6.03 million	$0.03	361.63
NetObjects	N/A	N/A	N/A	N/A	N/A

Enfusion has higher revenue and earnings than NetObjects.

Volatility and Risk

Enfusion has a beta of 0.92, meaning that its share price is 8% less volatile than the S&P 500. Comparatively, NetObjects has a beta of 0.87, meaning that its share price is 13% less volatile than the S&P 500.

Analyst Recommendations

This is a summary of current ratings for Enfusion and NetObjects, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Enfusion	0	2	2	0	2.50
NetObjects	0	0	0	0	0.00

Enfusion presently has a consensus target price of $11.83, suggesting a potential upside of 9.07%. Given Enfusion’s stronger consensus rating and higher possible upside, analysts clearly believe Enfusion is more favorable than NetObjects.

Institutional and Insider Ownership

81.1% of Enfusion shares are owned by institutional investors. 36.4% of Enfusion shares are owned by company insiders. Comparatively, 13.6% of NetObjects shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Profitability

This table compares Enfusion and NetObjects’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Enfusion	1.70%	6.67%	4.86%
NetObjects	N/A	N/A	N/A

Summary

Enfusion beats NetObjects on 10 of the 10 factors compared between the two stocks.

About Enfusion

Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. It also offers Accounting/General Ledger System, a real-time accounting book of record for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion Analytics System, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services. Enfusion, Inc. was founded in 1997 and is headquartered in Chicago, Illinois.

About NetObjects

NetObjects Inc. provides web design software and templates. The company offers NetObjects Fusion, a web design software that enables to build, manage, and promote websites; and NetObjects Fusion Essentials, a free drag-and-drop website builder. It also provides NetObjects Mosaic, an online application for mobile website designing; and publishes website for photographers. The company was founded in 1996 and is based in Doylestown, Pennsylvania.